Spots Global Cancer Trial Database for fluorescence guided surgery
Every month we try and update this database with for fluorescence guided surgery cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma | NCT04305470 | Meningioma | Gleolan (Aminol... | 18 Years - | NX Development Corp | |
FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 | NCT05518071 | Pancreas Adenoc... Cholangiocarcin... | CRGD-ZW800-1 Intraoperative ... | 18 Years - | Leiden University Medical Center | |
Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid) | NCT05929456 | Glioblastoma High-grade Glio... | Cetuximab-IRDye... | 18 Years - | University Medical Center Groningen | |
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) | NCT05804370 | Ovarian Cancer | Gleolan | 18 Years - | NX Development Corp | |
Fluorescence Targeted Pelvic Lymph Node Mapping | NCT03204994 | Cancer of Rectu... Lymph Node Dise... | Indocyanine Gre... | 18 Years - | Oxford University Hospitals NHS Trust | |
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) | NCT05804370 | Ovarian Cancer | Gleolan | 18 Years - | NX Development Corp | |
Fluorescence Targeted Pelvic Lymph Node Mapping | NCT03204994 | Cancer of Rectu... Lymph Node Dise... | Indocyanine Gre... | 18 Years - | Oxford University Hospitals NHS Trust | |
Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green | NCT06155734 | Paraganglioma | Fluorescence gu... | 18 Years - | Leiden University Medical Center | |
Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery | NCT03070613 | Colorectal Canc... Colorectal Neop... Colorectal Poly... | Fluorescent Lec... | 18 Years - | University of Oxford | |
Evaluation of Resection Quality of Cerebral Metastases Using Fluorescence Guided Surgery: a Prospective Randomised Study | NCT04116801 | Cerebral Metast... Fluorescence Gu... | microsurgical r... | 18 Years - 85 Years | Ramsay Générale de Santé | |
MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer | NCT05633836 | Ovarian Cancer | Fluorescence gu... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) | NCT05804370 | Ovarian Cancer | Gleolan | 18 Years - | NX Development Corp | |
Evaluation of Resection Quality of Cerebral Metastases Using Fluorescence Guided Surgery: a Prospective Randomised Study | NCT04116801 | Cerebral Metast... Fluorescence Gu... | microsurgical r... | 18 Years - 85 Years | Ramsay Générale de Santé | |
Evaluation of Resection Quality of Cerebral Metastases Using Fluorescence Guided Surgery: a Prospective Randomised Study | NCT04116801 | Cerebral Metast... Fluorescence Gu... | microsurgical r... | 18 Years - 85 Years | Ramsay Générale de Santé | |
MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer | NCT05633836 | Ovarian Cancer | Fluorescence gu... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Real-time Margin Assessment in Head and Neck Cancer | NCT05499065 | Head and Neck C... Head and Neck S... | Fluorescence gu... Cetuximab-IRDye... | 18 Years - | University Medical Center Groningen |